MyD88 signaling in nonhematopoietic cells protects mice against induced colitis by regulating specific EGF receptor ligands.
Toll-like receptors (TLRs) trigger intestinal inflammation when the epithelial barrier is breached by physical trauma or pathogenic microbes. Although it has been shown that TLR-mediated signals are ultimately protective in models of acute intestinal inflammation [such as dextran sulfate sodium (DSS...
Main Authors: | Brandl, K, Sun, L, Neppl, C, Siggs, O, Le Gall, S, Tomisato, W, Li, X, Du, X, Maennel, D, Blobel, C, Beutler, B |
---|---|
פורמט: | Journal article |
שפה: | English |
יצא לאור: |
2010
|
פריטים דומים
-
Blocking MyD88 signaling with MyD88 inhibitor prevents colitis-associated colorectal cancer development by maintaining colonic microbiota homeostasis
מאת: Bin Xie, et al.
יצא לאור: (2023-12-01) -
MyD88 Mediates Colitis- and RANKL-Induced Microfold Cell Differentiation
מאת: Yang Li, et al.
יצא לאור: (2021-12-01) -
Schisandrin B Attenuates Diabetic Cardiomyopathy by Targeting MyD88 and Inhibiting MyD88‐Dependent Inflammation
מאת: Wu Luo, et al.
יצא לאור: (2022-11-01) -
Soyasaponins reduce inflammation by downregulating MyD88 expression and suppressing the recruitments of TLR4 and MyD88 into lipid rafts
מאת: Junbin Chen, et al.
יצא לאור: (2020-06-01) -
MyD88 contribution to ocular surface homeostasis.
מאת: Rose Y Reins, et al.
יצא לאור: (2017-01-01)